Acrux LimitedASX: ACR

Launch of 90 gram pack size of Dapsone 5%, Gel in US

· Issued by Acrux Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

This topical prescription medicine is used to treat acne vulgaris and the annual market sales for similar products have been significant. The CEO mentioned that offering both pack sizes is expected to enhance the product's competitive profile and market share.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Acrux Limited on 6ix

Story so far

Earlier from Acrux

Later from Acrux

All Acrux news releases